Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Soleno Therapeutics Inc (SLNO)

1.85 0.05 (2.78%)

04-20 15:59

Open:

1.8342

Pre. Close:

1.8

High:

1.88

Low:

1.8

Volume:

16,750

Market Cap:

36M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.882 - 1.891

1.891 - 1.899

Low:

1.779 - 1.789

1.789 - 1.798

Close:

1.834 - 1.851

1.851 - 1.865

Technical analysis  (as of: 2018-04-20 4:33:38 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 2.36     One year: 2.76

Support:

Support1: 1.73    Support2: 1.55

Resistance:

Resistance1: 2.02    Resistance2: 2.36

Pivot:

1.81

Moving Averages:

MA(5): 1.82     MA(20): 1.83

MA(100): 1.77     MA(250): 2.29

MACD:

MACD(12,26):     Signal(12,26,9):

%K %D:

%K(14,3): 60.74     %D(3): 59.01

RSI:

RSI(14): 53.65

52-Week:

High: 3.75  Low: 1.317  Change(%): -33.9

Average Vol(K):

3-Month: 3289  10-Days 3243

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SLNO has closed below upper band by 4.5%. Bollinger Bands are 75.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to SLNO's normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-02-21T11:49:59-05:00
Your Daily Pharma Scoop: Portola Update, Wave Life Sciences To Collaborate With Takeda, AbbVie Reports Data For Egolix

2017-12-21T00:18:09-05:00
Daily Insider Ratings Round Up 12/19/17: BAS, GBT, PSEC, DRNA, SLNO

2017-12-12T12:50:18-05:00
Soleno Therapeutics secures private $15M capital raise; shares up 2%

2017-12-11T07:00:00-05:00
Your Daily Pharma Scoop: Celgene Upside, Erytech Tumbles, Novartis Neulasta Biosimilar

2017-12-08T08:42:47-05:00
Soleno up 16% premarket on move away from Capnia

2017-10-12T09:55:41-04:00
EMA advisory group backs Orphan Drug tag for Soleno's DCCR for Prader-Willi syndrome; shares up 2%

2017-05-11T16:35:20-04:00
Capnia misses by $0.04, beats on revenue

2017-03-15T16:36:57-04:00
Capnia beats by $0.07, misses on revenue

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Equipment Supplies Distribution

Shares Out. (M)

19.49

Shares Float (M)

17.07

% Held by Insiders

24.20

% Held by Institutions

73.80

Shares Short (K)

110

Shares Short Prior Month (K)

63

Stock Financials

EPS

EPS Est. Current Year

-1.350

EPS Est. Next Year

-1.050

EPS Est. Next Quarter

-0.250

Forward EPS

-0.790

Book Value (p.s.)

1.320

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-70.3

Return on Equity (ttm)

-104.6

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.95

Levered Free Cash Flow (M)

-3.08

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

1.40

P/S

P/CF

-3.62

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-10-06

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.